[20120626]R42564_FDA使用费和药物、生物制品和设备监管：S.3187与H.R.的比较分析5651.pdf

1、CRS Report for CongressPrepared for Members and Committees of Congress FDA User Fees and the Regulation of Drugs, Biologics, and Devices: Comparative Analysis of S. 3187 and H.R. 5651 -name redacted-, Coordinator Specialist in Drug Safety and Effectiveness -name redacted- Analyst in Health Policy -n

2、ame redacted- Analyst in Public Health and Epidemiology -name redacted- Specialist in Health Policy -name redacted- Specialist in Biomedical Policy -name redacted- Specialist in Public Health and Epidemiology -name redacted- Specialist in Health Policy June 26, 2012 Congressional Research Service 7-. www.crs.gov R42564